The role of anti-epidermal growth factor receptor and anti-vascular endothelial growth factor therapies in the treatment of non-small-cell lung cancer.
about
Genotypes and haplotypes of the VEGF gene and survival in locally advanced non-small cell lung cancer patients treated with chemoradiotherapy.[Bevacizumab combined with chemotherapy for advanced non-small cell lung cancer: a meta-analysis].Genetic modification of neurons to express bevacizumab for local anti-angiogenesis treatment of glioblastoma.Diallyl trisulfide inhibits migration, invasion and angiogenesis of human colon cancer HT-29 cells and umbilical vein endothelial cells, and suppresses murine xenograft tumour growth.Non-coding rRNA-mediated preferential killing in cancer cells is enhanced by suppression of autophagy in non-transformed counterpart.Peritoneal and meningeal relapse from lung adenocarcinoma after a response to gefitinib: A case report.Stem cell and lung cancer development: blaming the Wnt, Hh and Notch signalling pathway.Emerging antibody combinations in oncology.Second-line treatment of non-small-cell lung cancer: chemotherapy or tyrosine kinase inhibitors?Physiological and pathological angiogenesis in the adult pulmonary circulation.Hypoxia regulates the sperm associated antigen 4 (SPAG4) via HIF, which is expressed in renal clear cell carcinoma and promotes migration and invasion in vitro.A case of cicatricial alopecia associated with erlotinib.Cytoplasmic HuR expression correlates with angiogenesis, lymphangiogenesis, and poor outcome in lung cancer.Absence of BRAF mutation in pediatric and adolescent germ cell tumors indicate biological differences to adult tumors.Molecular Mechanisms Underlying the Inhibitory Effects of Qingzaojiufei Decoction on Tumor Growth in Lewis Lung Carcinoma.The efficacy and safety of paclitaxel and carboplatin with versus without bevacizumab in patients with non-small-cell lung cancer: a systematic review and meta-analysis.
P2860
Q33659635-899C81F6-0802-4872-93CF-7DDE5346A59BQ34593475-10979E48-0D07-4F65-ACBB-90B2CDADC794Q34943946-5D48CD2A-A1B8-422F-9386-4B1A48A4D4BEQ35531332-7BA08BC1-33FF-40B6-90AB-3823C59B3628Q35657091-9CDFAF0E-7BFD-4784-AF7C-A7F9CD76BEA7Q37560791-7EB6698F-B1A4-43A3-A88B-573677114625Q37842959-2AF401F8-6BDA-4081-8CEE-4964F0E1EB7BQ37893414-0C49E418-8EC1-42A6-AF79-582E7AA87BEBQ37945643-63A6375C-4B1D-4155-A4A5-69C424DA1607Q38111715-1A7F8839-72A9-4DD4-A369-05E2269DD99DQ39131858-4CE02FC9-4AE5-4DBF-B94B-E94DDAF38064Q41002715-5350AAA1-1B3E-4505-84C0-87B784D23F9FQ46137025-C8FDF909-5D22-453C-97AD-39C1C5F3BCAAQ46617822-B6822B23-C666-4CA8-94A5-814984FCD880Q50943660-50E48B9A-9731-42AA-B930-FFF53EA88290Q55083555-DFA43770-32C4-4809-855D-3C9EADFB4556
P2860
The role of anti-epidermal growth factor receptor and anti-vascular endothelial growth factor therapies in the treatment of non-small-cell lung cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The role of anti-epidermal gro ...... of non-small-cell lung cancer.
@en
The role of anti-epidermal gro ...... of non-small-cell lung cancer.
@nl
type
label
The role of anti-epidermal gro ...... of non-small-cell lung cancer.
@en
The role of anti-epidermal gro ...... of non-small-cell lung cancer.
@nl
prefLabel
The role of anti-epidermal gro ...... of non-small-cell lung cancer.
@en
The role of anti-epidermal gro ...... of non-small-cell lung cancer.
@nl
P356
P1433
P1476
The role of anti-epidermal gro ...... of non-small-cell lung cancer.
@en
P2093
Corey Langer
P356
10.3816/CLC.2010.N.011
P407
P577
2010-03-01T00:00:00Z